p-TrkB protein levels were reduced in CRS mice (p < 0.05 vs. control), and BDT treatment significantly reversed this decrease (p < 0.01 vs. CRS group) (Figure 4D,E). This evidence concerns the gene NTRK2 and congenital rubella syndrome.